Teva Pharmaceutical Industries retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $-14.958B, a 9.4% increase year-over-year.
Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2024 were $-15.173B, a 12.11% increase from 2023.
Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2023 were $-13.534B, a 4.31% increase from 2022.
Teva Pharmaceutical Industries retained earnings (accumulated deficit) for 2022 were $-12.975B, a 23.23% increase from 2021.